Thx for the reply. I agree maybe in the future, years from now with multiple uses APPROVED for Leronlimab, then you could get to triple digits. My point was that I don’t believe Nader should be discussing triple digit or 4 digit price targets. That is not for a CEO to me promoting without an approved product or sales. That is the kind of talk that gets lawsuits in the future. Let’s say Leron gets approved for Covid and HIV this year, how many vials can be manufactured and sold? With a significant share count of 520M already, I would think $10-15 maybe $20 is possible. However triple digit and quad digit are not a reality and investors should know that. Docj knows me well. I am a long time investor with him in GNBT. However I trade ALOT now in stocks and options and doing quite well. So use reasonable expectations for CYDY stock price.
That being said, I am long CYDY and would be happy to get $10-15.
Good luck.
Market Data 
Markets 
AI
